Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 5/20 | 0.36 |
| ▸ | XDH | P47989 | 2/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.35 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | PDE2A | O00408 | 2/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20150425 | 0.95 | KIF11 (0.42) | MAT2AXDHKIF11ALOX5APFEN1 | |
| SCHEMBL20156224 | 0.91 | MAT2A (0.36) | MAT2AXDHKIF11PDE10ATSHR | |
| SCHEMBL20156180 | 0.90 | ALOX5AP (0.37) | XDHALOX5APFEN1SCN9APDE2A | |
| SCHEMBL20115134 | 0.90 | ALDH1A1 (0.33) | SMN1; SMN2 | |
| SCHEMBL20114889 | 0.89 | XDH (0.35) | XDHALOX5APFEN1SMN1; SMN2AR | |
| SCHEMBL20150426 | 0.86 | KIF11 (0.42) | MAT2AKIF11SCN9ASMN1; SMN2AR | |
| SCHEMBL21108809 | 0.86 | TSHR (0.38) | MAT2AXDHKIF11ALOX5APFEN1 | |
| SCHEMBL20115138 | 0.85 | ALDH1A1 (0.33) | KIF11SMN1; SMN2 | |
| SCHEMBL20156287 | 0.85 | GRM2 (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL20115015 | 0.84 | ALDH1A1 (0.34) | XDHKIF11ALOX5APFEN1SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | MAT2A 2283/4885XDH 122/4885KIF11 2577/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | MAT2A 2283/4885XDH 122/4885KIF11 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.